Author Correction: Non-small-cell lung cancer

被引：0
|
作者：
Lizza E. L. Hendriks [1 ]
Jordi Remon [2 ]
Corinne Faivre-Finn [3 ]
Marina C. Garassino [4 ]
John V. Heymach [5 ]
Keith M. Kerr [6 ]
Daniel S. W. Tan [7 ]
Giulia Veronesi [8 ]
Martin Reck [9 ]
机构：
[1] Maastricht University Medical Center,Department of Pulmonary Diseases, GROW
[2] Gustave Roussy,School for Oncology and Reproduction
[3] University of Manchester and The Christie NHS Foundation,Department of Cancer Medicine
[4] the University of Chicago,Radiotherapy Related Research
[5] University of Texas,Thoracic Oncology Program, Section of Hematology Oncology, Department of Medicine
[6] M. D. Anderson Cancer Center,Department of Thoracic/Head and Neck Medical Oncology
[7] Aberdeen Royal Infirmary and Aberdeen University Medical School,Department of Pathology
[8] Duke-NUS Medical School,National Cancer Centre Singapore
[9] IRCCS San Raffaele Scientific Institute,Department of Thoracic Surgery
[10] German Center of Lung Research,Airway Research Center North
来源：
Nature Reviews Disease Primers | / 11卷 / 1期
关键词：
D O I：
10.1038/s41572-025-00592-8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Erlotinib in non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, Antonio
    Malone, Paolo
    Colantuoni, Giuseppe
    Del Gaizo, Filomena
    Ferrara, Carmine
    Nicolella, Dario
    Guerriero, Ciro
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (15) : 2579 - 2592
  • [22] Osimertinib for non-small-cell Lung Cancer
    Alakus, Hakan
    Zander, Thomas
    Bruns, Christiane
    ONKOLOGE, 2018, 24 (02): : 174 - 176
  • [23] Adagrasib in Non-Small-Cell Lung Cancer
    Kotecha, Rupesh
    Sahgal, Arjun
    Mehta, Minesh P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (13): : 1238 - 1239
  • [24] Non-Small-Cell Lung Cancer: Then and Now
    Schiller, Joan H.
    Gandara, David R.
    Goss, Glenwood D.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) : 981 - 983
  • [25] Chemotherapy for non-small-cell lung cancer
    Satoh, H
    Sekizawa, K
    LANCET, 2001, 358 (9289): : 1270 - 1271
  • [26] Ifosfamide in non-small-cell lung cancer
    Rosell, R
    Martin, C
    Balaña, C
    ANNALS OF ONCOLOGY, 1999, 10 : 25 - 28
  • [27] Cetuximab in non-small-cell lung cancer
    Pirker, Robert
    Filipits, Martin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (01) : 54 - 60
  • [28] Cancer vaccines for non-small-cell lung cancer
    Palma, M.
    Choudhury, A.
    Mellstedt, H.
    MINERVA CHIRURGICA, 2009, 64 (06) : 643 - 653
  • [29] Treatment of non-small-cell lung cancer
    Lavolé, A
    Blanchon, F
    Breton, JL
    Milleron, B
    REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) : 175 - 178
  • [30] Bevacizumab for non-small-cell lung cancer
    Garassino, Marina Chiara
    Hollander, Lital
    Torri, Valter
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13): : 1373 - 1373
12345